GTR Home > Tests > Search results - Neurofibromatosis, type 2

Apply filters

Showing test for 1 condition

reset

Compare labs

Your search term can be found in tests with a total of 1694 conditions. Only 1000 conditions are displayed in this filter box. Please type the name of the condition in the search box in this filter to find the specific condition. You can use the filters below to narrow down your results.
If the name of the condition you typed is not present, please try another query or search using the All GTR tab.

More test methods
  • Hide states
More locations

GTR test search results for C0027832[DISCUI]

C Clinical test, R Research test

Showing 1 to 20 of 37 tests for 1 condition in 27 labs

CNeurofibromatosis type II

Lab: Centogene AG - the Rare Disease Company Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CNeurofibromatosis type II

Lab: Centogene AG - the Rare Disease Company Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CTruGenome Predisposition Screen

Lab: Illumina Clinical Services Laboratory Illumina San Diego, California, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (1541)
Total targets (1578)

CNeurofibromatosis Type 2 via the NF2 Gene

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CNEUROFIBROMATOSI DE TYPE 2 - NF2 gene

Test targets
Methods
  • D Deletion/duplication analysis
  • L Linkage analysis
  • E Sequence analysis of select exons

CNeurofibromatosis Type 2 DNA Sequencing Test

Lab: Athena Diagnostics Inc Marlborough, Massachusetts, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region

CNeurofibromatosis Type 2 (NF2) Evaluation

Lab: Athena Diagnostics Inc Marlborough, Massachusetts, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CNeurofibromatosis Type 2 (NF2) Duplication/Deletion Test

Lab: Athena Diagnostics Inc Marlborough, Massachusetts, United States
Test targets
Methods
  • D Deletion/duplication analysis

CNF2. Complete sequencing

Lab: Instituto de Medicina Genomica Paterna, Comunidad Valenciana, Spain
Test targets
Methods
  • C Sequence analysis of the entire coding region

CNF2. MLPA testing

Lab: Instituto de Medicina Genomica Paterna, Comunidad Valenciana, Spain
Test targets
Methods
  • D Deletion/duplication analysis

CHereditary Cancer Syndrome: Sequencing Panel

Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (107)
Total targets (46)

CHereditary Cancer NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (256)
Total targets (112)

CNeurofibromatosis II

Lab: MedGene Bratislava, Bratislava, Slovakia
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CNeurofibromatosis type 2 (sequence analysis of NF2 gene)

Lab: CGC Genetics Porto, Porto, Portugal
Test targets
Methods
  • C Sequence analysis of the entire coding region

CNeurofibromatosis type 2 (deletion/duplication analysis of NF2 gene)

Lab: CGC Genetics Porto, Porto, Portugal
Test targets
Methods
  • D Deletion/duplication analysis

CNeurofibromatosis II

Lab: Praxis fuer Humangenetik Wien Vienna, Wien, Austria
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CNeurofibromatosis type II: NF2 gene sequence analysis

Test targets
Methods
  • C Sequence analysis of the entire coding region

CNEUROFIBROMATOSIS, TYPE II; NF2

Lab: Human Genetics Ruhr University Bochum, Nordrhein-Westfalen, Germany
Test targets
Methods
  • D Deletion/duplication analysis
  • E Sequence analysis of select exons
  • C Sequence analysis of the entire coding region

CNeurofibromatosis type 2 (NF2) Comprehensive testing from biopsy specimen

Lab: Medical Genomics Laboratory Department of Genetics UAB Birmingham, Alabama, United States
Test targets
Methods
  • L Linkage analysis
  • C Sequence analysis of the entire coding region

Showing 1 to 20 of 37 tests for 1 condition in 27 labs

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Write to the Help Desk